Jeetinder Singh Mahal insider trades

Open-market stock purchases and sales by Jeetinder Singh Mahal, CEO and President at Jasper Therapeutics, Inc, from SEC Form 4 filings since Mar 21, 2022.

Recent trades

DateStockTradeValue
Feb 6, 2026JSPR Jasper Therapeutics, IncBought (not open market)—
Jan 2, 2026JSPR Jasper Therapeutics, IncBought (not open market)—

Companies traded

  • JSPR Jasper Therapeutics, Inc: 5 sales, last Feb 6, 2026

Get free alerts when Jeetinder Singh Mahal files a new trade →